pericarditis - Nursing Case Study
Pathophysiology
• Primary mechanism: Inflammation of the pericardial sac often due to infection, autoimmune response, or injury, leading to increased production of pericardial fluid or fibrin deposition, which causes the classical chest pain and may impair cardiac function.
• Secondary mechanism: The inflammatory process can result in pericardial effusion, where excess fluid accumulates in the pericardial space, potentially leading to increased pressure on the heart (cardiac tamponade), which decreases cardiac output and can cause hypotension.
• Key complication: Chronic inflammation may lead to constrictive pericarditis, where fibrous scarring and calcification of the pericardium restrict diastolic filling, resulting in symptoms of heart failure such as edema and exertional dyspnea.
Patient Profile
Demographics:
45-year-old male, construction worker
History:
• Key past medical history: Hypertension, previous episode of viral pericarditis two years ago
• Current medications: Lisinopril 10 mg daily, Ibuprofen 400 mg as needed for pain
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Sharp chest pain, worsening over the past three days
• Key symptoms: Chest pain radiating to the left shoulder, low-grade fever, fatigue, shortness of breath when lying down
• Vital signs: Temperature 100.4°F, Heart Rate 110 bpm, Blood Pressure 140/85 mmHg, Respiratory Rate 22 breaths per minute
Section 1
As the clinical team conducts an initial assessment, further examination reveals a pericardial rub, a characteristic sound indicative of pericarditis, on auscultation. The patient reports increased discomfort when lying flat and experiences relief when sitting up and leaning forward, a classic positional feature of pericarditis-related pain. Electrocardiogram (ECG) results demonstrate diffuse ST-segment elevations across multiple leads, consistent with pericardial inflammation rather than myocardial infarction. Given the patient's history of viral pericarditis, the team considers the possibility of a recurrent episode, likely exacerbated by his underlying hypertension.
Blood tests are conducted to explore inflammatory markers and potential underlying infections. The results reveal elevated C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), indicating systemic inflammation. Troponin levels are within normal limits, further supporting the diagnosis of pericarditis rather than myocardial injury. Additionally, an echocardiogram is performed, identifying a moderate pericardial effusion without signs of cardiac tamponade at this stage. The team discusses the need to closely monitor the effusion's size and potential hemodynamic impact, considering the risk of progression to tamponade if left unchecked.
As a response to the findings, the patient is started on colchicine in addition to ibuprofen to address the inflammation and reduce the risk of recurrence. The clinical team emphasizes the importance of monitoring for signs of complication, such as worsening shortness of breath or hypotension, which might indicate cardiac tamponade. A follow-up plan is established to reassess the effusion and inflammatory markers, ensuring that any changes in the patient's condition are promptly addressed. This comprehensive approach aims to manage the current episode effectively while mitigating the risk of progression to more severe complications like constrictive pericarditis.
Section 2
Several days into the treatment, the patient begins to exhibit new symptoms, prompting a reassessment. The patient reports increasing fatigue and mild shortness of breath, particularly during exertion. Upon physical examination, there is a noticeable increase in jugular venous distension, and distant heart sounds are detected, suggestive of hemodynamic changes. Vital signs reveal a slight drop in blood pressure, now reading at 100/60 mmHg, and a compensatory tachycardia with a heart rate of 110 beats per minute. These findings raise concern for the development of cardiac tamponade, a potential complication of the pericardial effusion.
In response to these changes, the clinical team orders an urgent repeat echocardiogram. The results show that the pericardial effusion has increased in size, now classified as large, with evidence of diastolic collapse of the right atrium, confirming the suspicion of cardiac tamponade. The team swiftly prepares for a pericardiocentesis to relieve the pressure on the heart. Meanwhile, laboratory tests indicate persistently elevated CRP and ESR levels, underscoring ongoing inflammation, but troponin levels remain normal, reaffirming the absence of myocardial injury.
The pericardiocentesis is successfully performed, and approximately 300 ml of serous fluid is aspirated, leading to immediate improvement in the patient's symptoms. Post-procedure, the patient's blood pressure stabilizes to 120/80 mmHg, and the heart rate decreases to 85 beats per minute. The clinical team revises the treatment plan to include closer monitoring of vital signs and serial echocardiograms to ensure the effusion does not reaccumulate. The patient is also advised on lifestyle modifications to help manage his hypertension, thereby reducing potential exacerbating factors for pericarditis recurrence. This pivotal intervention and subsequent management adjustments aim to prevent further complications and stabilize the patient's condition.
Section 3
Following the successful pericardiocentesis, the patient experiences a period of stabilization with improved hemodynamics, as evidenced by the normalization of blood pressure and heart rate. However, two days later, the patient reports a sudden onset of chest pain that is sharp and pleuritic in nature, exacerbated by deep breathing and changes in position. This prompts the clinical team to conduct a thorough reassessment to rule out any new complications or recurrence of the pericardial effusion.
A repeat echocardiogram is ordered, revealing no significant reaccumulation of pericardial fluid but showing mild pleural effusion on the left side. Laboratory tests indicate that CRP and ESR levels remain elevated, suggesting persistent inflammation. New laboratory results show a mild leukocytosis with a white blood cell count of 12,000/mm³, and the chest X-ray confirms the presence of a small pleural effusion. Despite these findings, cardiac biomarkers, including troponin, remain within normal limits, alleviating concerns about myocardial infarction.
Given the development of pleuritic chest pain and the appearance of pleural effusion, the clinical team considers the possibility of post-pericardiotomy syndrome, a known inflammatory response following pericardial intervention. The treatment plan is adjusted to include a short course of nonsteroidal anti-inflammatory drugs (NSAIDs) and colchicine to address the inflammatory component and manage symptoms. The patient is advised to continue monitoring for any new symptoms and to maintain regular follow-up appointments to ensure resolution of inflammation and to prevent further complications. The team emphasizes the importance of lifestyle modifications, particularly focusing on blood pressure control and avoiding tobacco and alcohol, to support overall cardiovascular health and prevent recurrence of pericarditis.
Section 4
As the patient continues with the adjusted treatment regimen, including NSAIDs and colchicine, the clinical team closely monitors for any changes in symptoms or new complications. Over the next 48 hours, the patient reports a noticeable reduction in chest pain, with the discomfort becoming less frequent and intense. However, during a routine assessment, the nurse observes that the patient appears slightly dyspneic, particularly when lying flat. Vital signs reveal a mild tachypnea with a respiratory rate of 22 breaths per minute, while oxygen saturation remains stable at 95% on room air. The patient's heart rate and blood pressure remain within normal limits, suggesting stable hemodynamics despite the respiratory changes.
To further investigate the dyspnea and ensure no new complications are developing, a follow-up chest X-ray is obtained. This reveals a slight increase in the size of the left-sided pleural effusion compared to previous imaging, raising concerns about potential respiratory compromise. Additionally, a pulmonary function test is performed, which indicates mild restrictive lung pattern, likely secondary to the pleural effusion. Given these findings, the decision is made to adjust the management plan to include diuretics to facilitate fluid reabsorption and alleviate pressure on the lungs, alongside ongoing anti-inflammatory treatment.
These developments prompt the clinical team to reinforce the importance of patient education on recognizing signs of respiratory distress and the need for immediate medical attention. The patient is advised to continue avoiding activities that exacerbate symptoms, such as lying flat for extended periods, and to maintain an upright position as much as possible. Regular follow-up appointments are scheduled to track the resolution of the pleural effusion and adjust treatment as necessary, ensuring a proactive approach to prevent further complications and support the patient’s recovery trajectory.
Section 5
As the patient continues with the adjusted treatment plan, including the addition of diuretics, the clinical team closely monitors for changes in the patient's respiratory status and overall condition. Over the next 24 hours, the patient's dyspnea shows slight improvement, with the respiratory rate decreasing to 20 breaths per minute. However, during a routine check, the nurse notes that the patient appears more fatigued and less responsive than usual. On further assessment, the patient's jugular venous pressure (JVP) is elevated, and auscultation reveals distant heart sounds, raising concerns about possible cardiac tamponade, a known complication of pericarditis and pleural effusion.
Given these new findings, an urgent echocardiogram is performed to assess for pericardial effusion and potential cardiac tamponade. The echocardiogram reveals a moderate pericardial effusion with evidence of right atrial and ventricular diastolic collapse, consistent with early signs of cardiac tamponade. This development necessitates immediate intervention to prevent hemodynamic instability. The decision is made to perform a pericardiocentesis to relieve the pressure on the heart and restore normal cardiac function.
Following the pericardiocentesis, which successfully removes a significant volume of fluid, the patient's condition improves rapidly. The fatigue and distant heart sounds resolve, and the patient reports feeling more alert and comfortable. Vital signs stabilize, with the heart rate normalizing and blood pressure remaining stable. The clinical team emphasizes the importance of continued monitoring and education on recognizing symptoms that could indicate recurrence of effusion or tamponade, ensuring that the patient is well-equipped to manage their condition post-discharge. Follow-up echocardiograms are scheduled to monitor for recurrent effusion, and the treatment plan is adjusted to maintain anti-inflammatory therapy and diuretics, as appropriate, to support the patient's recovery and prevent further complications.